ALLO Shares Outstanding History



Below is a table of the ALLO shares outstanding history going back to 10/11/2018:

Date ALLO Shares Outstanding
10/11/2018113.69M
11/15/2018121.48M
3/4/2019121.48M
5/3/2019121.54M
8/2/2019121.75M
6/30/2019145.98M
11/1/2019121.90M
2/24/2020124.91M
5/4/2020125.33M
8/3/2020139.29M
11/2/2020140.28M
2/22/2021140.65M
5/3/2021141.54M
8/2/2021142.18M
11/2/2021142.52M
2/21/2022142.75M
5/2/2022143.60M
8/5/2022143.81M
10/31/2022144.21M
5/1/2023145.84M
7/31/2023167.63M
10/31/2023168.28M

Also see: ALLO Market Cap History
ALLO YTD Return
ALLO Historical Shares Outstanding:
+8.06% CAGR
ALLO Historical Shares Outstanding: +8.06% CAGR

Mouse over chart for data details
10/11/2018 ...10/31/2023
Allogene Therapeutics is a clinical stage immuno-oncology company focused on the development of genetically engineered allogeneic T cell therapies for the treatment of cancer. Co.'s key product candidates, ALLO-501 and ALLO-501A, are engineered allogeneic Chimeric antigen receptor (CAR) T cell therapies that target CD19, a protein expressed on the cell surface of B cells and a validated target for B cell driven hematological malignancies. Co. is also developing engineered allogeneic CAR T cell product candidates for multiple myeloma, clear cell renal cell carcinoma, and other blood cancers and solid tumors. We show 22 historical shares outstanding datapoints in our coverage of ALLO's shares outstanding history.

Understanding the changing numbers of ALLO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALLO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALLO by allowing them to research ALLO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ALLO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Allogene Therapeutics (ALLO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ALLR Shares Outstanding History
ALNA Shares Outstanding History
ALNY Shares Outstanding History
ALOG Shares Outstanding History
ALPN Shares Outstanding History
ALQA Shares Outstanding History
ALRN Shares Outstanding History
ALT Shares Outstanding History
ALVR Shares Outstanding History
ALXN Shares Outstanding History
More Healthcare companies »

 

ALLO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.